Dr. Greg Gerdeman, serves on our board of advisors and is a neuroscientist and pioneer in understanding the mammalian endocannabinoid system, including its roles in synaptic plasticity, neuroprotection, and the “runner’s high” evoked by aerobic exercise. He has studied and lectured on cannabinoid pharmacology for over two decades, both as an academic and a cannabis industry scientist.